Rebecca Colman1, Lianne G Singer2, Reeta Barua3, James Downar4. 1. Division of Respirology, Department of Medicine, University of Toronto, Toronto, ON, Canada. 2. Division of Respirology, Department of Medicine, University of Toronto, Toronto, ON, Canada Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada. 3. Faculty of Medicine, Queen's University, Kingston, ON, Canada. 4. Division of Respirology, Department of Medicine, University of Toronto, Toronto, ON, Canada Division of Palliative Care, Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada james.downar@utoronto.ca.
Abstract
BACKGROUND: Lung transplant candidates experience important symptoms, but they are rarely referred for palliative care consultation until they are deemed ineligible for transplant. Our lung transplant service has a high rate of palliative care referral for patients awaiting transplant. AIM: We reviewed the characteristics, interventions, and outcomes of lung transplant candidates referred for co-management by palliative care, to determine whether they safely received opioids and went on to transplantation. DESIGN AND PARTICIPANTS: Retrospective review of lung transplant candidates referred to our palliative care consultation service between January 2010 and May 2012. RESULTS: Of 308 lung transplant candidates, 64 (20.7%) were referred to palliative care. Most had interstitial lung disease and were referred for dyspnea and a rapidly deteriorating course. A total of 59 (92%) were prescribed opioids for dyspnea, 55/59 used the opioids more than once, and 38/59 were maintained on standing opioids. There were no episodes of clinically important opioid toxicity or respiratory depression, and there was a trend toward increased exertion during exercise sessions post-opioid versus pre-opioid (19.3 vs 17.0 kcal, respectively, p = 0.06). At last follow-up, 30 (47%) had been transplanted, 23 (36%) had died while on the wait-list, 9 (14%) had died after delisting, and 2 (3%) were still awaiting transplantation. Of the 30 patients who underwent lung transplantation, only 7 (23%) still required an opioid prescription 1 month post-discharge. CONCLUSION: In lung transplant candidates, palliative care and opioids in particular can be safely provided without compromising eligibility for transplantation. Palliative care should not be delayed until a patient is deemed ineligible for transplant.
BACKGROUND: Lung transplant candidates experience important symptoms, but they are rarely referred for palliative care consultation until they are deemed ineligible for transplant. Our lung transplant service has a high rate of palliative care referral for patients awaiting transplant. AIM: We reviewed the characteristics, interventions, and outcomes of lung transplant candidates referred for co-management by palliative care, to determine whether they safely received opioids and went on to transplantation. DESIGN AND PARTICIPANTS: Retrospective review of lung transplant candidates referred to our palliative care consultation service between January 2010 and May 2012. RESULTS: Of 308 lung transplant candidates, 64 (20.7%) were referred to palliative care. Most had interstitial lung disease and were referred for dyspnea and a rapidly deteriorating course. A total of 59 (92%) were prescribed opioids for dyspnea, 55/59 used the opioids more than once, and 38/59 were maintained on standing opioids. There were no episodes of clinically important opioid toxicity or respiratory depression, and there was a trend toward increased exertion during exercise sessions post-opioid versus pre-opioid (19.3 vs 17.0 kcal, respectively, p = 0.06). At last follow-up, 30 (47%) had been transplanted, 23 (36%) had died while on the wait-list, 9 (14%) had died after delisting, and 2 (3%) were still awaiting transplantation. Of the 30 patients who underwent lung transplantation, only 7 (23%) still required an opioid prescription 1 month post-discharge. CONCLUSION: In lung transplant candidates, palliative care and opioids in particular can be safely provided without compromising eligibility for transplantation. Palliative care should not be delayed until a patient is deemed ineligible for transplant.
Authors: Catherine R Butler; Peter P Reese; James D Perkins; Yoshio N Hall; J Randall Curtis; Manjula Kurella Tamura; Ann M O'Hare Journal: J Am Soc Nephrol Date: 2020-09-09 Impact factor: 10.121
Authors: Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos Journal: J Heart Lung Transplant Date: 2021-07-24 Impact factor: 13.569
Authors: Yasuhiro Yamaguchi; K M Saif-Ur-Rahman; Motoko Nomura; Hiromitsu Ohta; Yoshihisa Hirakawa; Takashi Yamanaka; Satoshi Hirahara; Hisayuki Miura Journal: Int J Environ Res Public Health Date: 2022-04-18 Impact factor: 4.614
Authors: Eric Nolley; Jessica Fleck; Dio Kavalieratos; Mary Amanda Dew; Daniel Dilling; Rebecca Colman; Maria M Crespo; Hiliary Goldberg; Steven Hays; Ramsey Hachem; Erika Lease; James Lee; John Reynolds; Matthew Morrell; Yael Schenker Journal: J Palliat Med Date: 2020-01-02 Impact factor: 2.947
Authors: Krista L Lentine; Paolo R Salvalaggio; Yasar Caliskan; Ngan N Lam; Mara McAdams-DeMarco; David Axelrod; Dorry L Segev; Larissa Myaskovsky; Mary Amanda Dew; Heather Bruschwein; Deborah J Levine; Stuart Sweet; Gregory P Hess; Bertram L Kasiske; Mark A Schnitzler Journal: J Heart Lung Transplant Date: 2021-02-17 Impact factor: 13.569
Authors: Lisa Wickerson; Dmitry Rozenberg; Tania Janaudis-Ferreira; Robin Deliva; Vincent Lo; Gary Beauchamp; Denise Helm; Chaya Gottesman; Polyana Mendes; Luciana Vieira; Margaret Herridge; Lianne G Singer; Sunita Mathur Journal: World J Transplant Date: 2016-09-24